Markus A. Riederer - Search Results

Year	Number of Results
2002	3
2004	1
2005	1
2006	1
2012	2
2013	2
2014	2
2015	1
2017	1
2021	4
2022	3
2024	0

1

The potency of selatogrel, a reversible antagonist of the P2Y12 receptor, is affected by calcium concentration.

Baumann M, Lack B, Guillaumat I, Murphy MJ, Riederer MA. Baumann M, et al. Among authors: riederer ma. Platelets. 2022 Jan 2;33(1):147-156. doi: 10.1080/09537104.2020.1869711. Epub 2021 Jan 11. Platelets. 2022. PMID: 33427002

2

Selatogrel and Other P2Y12 Inhibitors' Putative Off-Target Effects.

Valgimigli M, Storey RF, Sinnaeve PR, Riederer MA, Bernaud C, Frenoux JM. Valgimigli M, et al. Among authors: riederer ma. J Cardiovasc Pharmacol. 2022 Feb 1;79(2):153-154. doi: 10.1097/FJC.0000000000001135. J Cardiovasc Pharmacol. 2022. PMID: 34475343 No abstract available.

3

The P2Y12 Receptor Antagonist Selatogrel Dissolves Preformed Platelet Thrombi In Vivo.

Crescence L, Kramberg M, Baumann M, Rey M, Roux S, Panicot-Dubois L, Dubois C, Riederer MA. Crescence L, et al. Among authors: riederer ma. J Clin Med. 2021 Nov 17;10(22):5349. doi: 10.3390/jcm10225349. J Clin Med. 2021. PMID: 34830631 Free PMC article.

4

Inverse agonist efficacy of selatogrel blunts constitutive P2Y12 receptor signaling by inducing the inactive receptor conformation.

Pons V, Garcia C, Tidten-Luksch N, Mac Sweeney A, Caroff E, Galés C, Riederer MA. Pons V, et al. Among authors: riederer ma. Biochem Pharmacol. 2022 Dec;206:115291. doi: 10.1016/j.bcp.2022.115291. Epub 2022 Oct 25. Biochem Pharmacol. 2022. PMID: 36306820 Free article.

5

Selatogrel, a reversible P2Y12 receptor antagonist, has reduced off-target interference with haemostatic factors in a mouse thrombosis model.

Crescence L, Darbousset R, Caroff E, Hubler F, Riederer MA, Panicot-Dubois L, Dubois C. Crescence L, et al. Among authors: riederer ma. Thromb Res. 2021 Apr;200:133-140. doi: 10.1016/j.thromres.2021.01.026. Epub 2021 Feb 6. Thromb Res. 2021. PMID: 33610885 Free article.

6

Insights from In Vitro and Clinical Data to Guide Transition from the Novel P2Y12 Antagonist Selatogrel to Clopidogrel, Prasugrel, and Ticagrelor.

Schilling U, Dingemanse J, Dobrow M, Baumann M, Riederer MA, Juif PE, Ufer M. Schilling U, et al. Among authors: riederer ma. Thromb Haemost. 2021 Jun;121(6):755-766. doi: 10.1055/s-0040-1721773. Epub 2021 Jan 7. Thromb Haemost. 2021. PMID: 33412611 Clinical Trial.

7

The reversible P2Y₁₂ antagonist ACT-246475 causes significantly less blood loss than ticagrelor at equivalent antithrombotic efficacy in rat.

Rey M, Kramberg M, Hess P, Morrison K, Ernst R, Haag F, Weber E, Clozel M, Baumann M, Caroff E, Hubler F, Riederer MA, Steiner B. Rey M, et al. Among authors: riederer ma. Pharmacol Res Perspect. 2017 Oct;5(5):e00338. doi: 10.1002/prp2.338. Pharmacol Res Perspect. 2017. PMID: 28805949 Free PMC article.

8

Identification of 2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid (setipiprant/ACT-129968), a potent, selective, and orally bioavailable chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) antagonist.

Fretz H, Valdenaire A, Pothier J, Hilpert K, Gnerre C, Peter O, Leroy X, Riederer MA. Fretz H, et al. Among authors: riederer ma. J Med Chem. 2013 Jun 27;56(12):4899-911. doi: 10.1021/jm400122f. Epub 2013 Jun 13. J Med Chem. 2013. PMID: 23721423

9

P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in mice.

Darbousset R, Delierneux C, Mezouar S, Hego A, Lecut C, Guillaumat I, Riederer MA, Evans RJ, Dignat-George F, Panicot-Dubois L, Oury C, Dubois C. Darbousset R, et al. Among authors: riederer ma. Blood. 2014 Oct 16;124(16):2575-85. doi: 10.1182/blood-2014-04-571679. Epub 2014 Aug 22. Blood. 2014. PMID: 25150292 Free PMC article.

10

4-((R)-2-{[6-((S)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than Clopidogrel.

Caroff E, Hubler F, Meyer E, Renneberg D, Gnerre C, Treiber A, Rey M, Hess P, Steiner B, Hilpert K, Riederer MA. Caroff E, et al. Among authors: riederer ma. J Med Chem. 2015 Dec 10;58(23):9133-53. doi: 10.1021/acs.jmedchem.5b00933. Epub 2015 Nov 18. J Med Chem. 2015. PMID: 26550844

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

19 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year